1. Home
  2. |Insights
  3. |FDLI's Introduction to Biologics and Biosimilars Law and Regulation

FDLI's Introduction to Biologics and Biosimilars Law and Regulation

Event | 09.30.19 - 10.01.19, 8:00 PM EDT - 8:00 PM EDT

Address

Sidley Austin LLP
1501 K Street NW, Suite 600, Washington, D.C. 20005

Partner Deborah Yellin and Senior Counsel Dr. Mary Anne Schofield, will be presenting "Biosimilar Biological Products" as part of the Food and Drug Law Institute’s Introduction to Biologics and Biosimilars Law and Regulation course in Washington, D.C., October 1-2. The two-day course explores the regulation of biological products, including biotechnology–derived therapeutic proteins, human tissue, gene, and cell products. Attendees will also gain a comprehensive understanding of the various administrative agencies that impact these industries. 

For more information, please visit these areas: IP Prosecution and Portfolio Management, Intellectual Property

Participants

Insights

Event | 02.25.25

Charting a Path for Compliance in Life Sciences

Join us for an interactive and educational event tailored for biotech leaders seeking to ensure security compliance while leveraging the power of Amazon Web Services (AWS). This session will dive into the critical elements of designing secure, scalable, and compliant systems for biotech operations, from research and development to clinical trials and beyond....

View All Insights